Skip to search formSkip to main contentSkip to account menu

LB 20304

Known as: LB-20304, LB20304 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

gemifloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areas.
1999
1999
Studies To Establish Quality Control Ranges for SB-265805 (LB20304) When Using National Committee for Clinical Laboratory Standards Antimicrobial Susceptibility Test Methods
SB-265805, formerly LB20304, is a novel naphthridone compound in the fluoroquinolone class of antimicrobial agents. This… 
1997
1997
Antimicrobial activity of LB20304, a fluoronaphthyridone, tested against anaerobic bacteria.
1996
1996
원보 : 새로운 퀴놀론계 항생제 LB20304a 의 일반약리작용
General pharmacological studies of LB20304a (a mesylate salt form of a new quinolone antibiotic LB20304) following oral… 
1995
1995
Safety Evaluation of LB20304, a New Quinolone Antibiotic
General pharmacology of LB20304, a quinolone antibiotic, were examined in terms of general behaviour, cardiovascular, and central… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)